Ventricular Tachycardia Clinical Trial
Official title:
Quantitative Measurements Comparing Body Surface Potentials During Pacemapping and Spontaneous Ventricular Tachycardia
Patients sometimes suffer from life-threatening abnormal heart racing that originates from the lower chamber of the heart. These patients will often need an implantable defibrillator which has the ability to shock the heart back to a normal heart rhythm, but this does not prevent them from getting frequent recurrences of the bad heart rhythm needing shocks from the device. This can be painful and potentially harmful. Medicines to prevent recurrences of shocks are not very effective and have many side effects. An alternative to medicines for this is a procedure called a catheter ablation in which a wire is passed up through the blood vessels of the leg into the heart and used to find the short circuits which cause the dangerous heart rhythm. When the spot causing the trouble is found, the investigators can burn it ("ablate" it). This procedure is challenging and methods are needed to make it more effective and easier to do. One of the main ways for finding the short circuits involves using the electrocardiogram (the "ECG"). The regular ECG is simplistic and only makes use of recordings from 10 sites (6 precordial sites and 4 sites on both upper and lower limbs) on the body surface. The investigators are testing whether making recordings from 120 sites on the chest and back and using special computerized analysis of the recordings can help make catheter ablation for dangerous heart rhythms more effective.
Several conventional and advanced mapping techniques are frequently utilized to accomplish a
successful catheter ablation. Many of these mapping techniques (activation mapping,
entrainment mapping) are hampered by either hemodynamic instability of some tachycardias or
non-sustainability of others. Pacemapping is a commonly used tool for mapping non-sustained
or hemodynamically unstable VT, which is based upon the principle that activation of the
heart from a given site will yield a reproducible body surface electrocardiogram (ECG)
morphology and that pacing from a site very close to the site at which VT activates the
heart will result in a matching ECG morphology. This technique, however, is limited by
imperfect accuracy and spatial resolution, subjectivity of interpretation leading to marked
inter-observer variability in the perceived quality of a morphologic match, and by the need
for an intuitive interpretation of the ECG to direct catheter manipulation. We hypothesize
that one can improve the accuracy with which the origin of VT is localized by applying body
surface potential mapping (BSPM), using data derived from 120 simultaneously acquired ECGs.
Objectives:
1. To quantify the similarity between BSPM waveforms during induced VT and during
pacemapping or between two different pacing sites using two waveform comparison
metrics, the correlation coefficient (CORR) and the root mean square error (RMSE) and
to test the validity of these metrics as markers of proximity of the pacing site to the
site of earliest ventricular activation.
2. To compare the accuracy with which the origin of ventricular tachycardia is localized
via pacemapping by applying (BSPM), which uses data derived from 120 simultaneously
acquired ECGs, to the accuracy of localization with different ECG subsets e.g. 12-lead
ECG and X, Y and Z leads.
Patient and methods:
We anticipate that our patients will fall in one of the flowing 4 groups:
Group A:Patients with focal VT in structurally normal heart. Group B:Patients with scar
related VT in which the exit site can be identified. Group C:Patients with scar related VT
in which the exit site cannot be identified.Group D:Patients presenting with SVT.
For all groups, data for body-surface potential mapping (BSPM) will be recorded during
induced VT (Group A& B), pacing from virtual VT exit sites which are several points selected
around the scar margin to represent the VT exit site (group C) or index pacing site which is
a pacing site selected as a reference in the RV of patients presented with SVT (group D) and
from different pacemapping sites including successful and unsuccessful ablation sites if
applicable. All data will be imported into customized software.
The improvement in the arithmetic value of the two comparison metrics will be tested as the
site of pacing approaches the site of earliest ventricular activation (Groups A&B) or
virtual VT exit sites in group C or the index pacing site (in group D). The best CORR and
RMSE between the BSPM obtained during VT (in group A and B)/virtual VT exit sites (in group
C) or index pacing site (group D) and different pacing sites (including successful and
unsuccessful ablation sites) will be recorded. A simple linear regression will be used to
compare the CORR and RMSE difference at each pacing site to distance between this pacing
site and the successful ablation site as a surrogate of the best pace-match (in group A and
B) or the corresponding virtual VT exit site (in group C) or index pacing site (group D). P
value <0.05 will be considered significant. The mean sensitivity, specificity, and positive-
and negative-predictive accuracies of the arithmetic metrics in determining the VT
origin/exit site will be determined. We will repeat the previous protocol using different
ECG subsets including 12 lead ECGs and X, Y and Z leads. The predictive accuracies for
different subsets of electrodes will be measured and compared to those derived from using
the whole BSPM obtained from the 120 ECG leads.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03453645 -
Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation
|
||
Completed |
NCT05791032 -
Sub Chronic Evaluation for ATP With an Extravascular Placed ICD Lead (STEP ICD) Study
|
N/A | |
Completed |
NCT05970120 -
A Study of Intracardiac Ultrasound With the NUVISION NAV Ultrasound Catheter
|
N/A | |
Completed |
NCT04011631 -
Evaluation of the iD-SystemTM, One-Handed Disposable Internal Defibrillation System.
|
N/A | |
Recruiting |
NCT03536052 -
Ablation at Virtual-hEart pRedicted Targets for VT
|
N/A | |
Not yet recruiting |
NCT06063811 -
Ventricular Tachycardia Ablation in LVAD Patients
|
||
Enrolling by invitation |
NCT02962076 -
Study of Cardiac PET/CT Imaging to Guide Ablation Treatment of Ventricular Tachycardia
|
Early Phase 1 | |
Not yet recruiting |
NCT02784912 -
Biomarkers in Risk Stratification of Sustainted Ventricular Tachycardia or Electrical Storm After Ablation
|
N/A | |
Completed |
NCT01791543 -
Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia
|
N/A | |
Terminated |
NCT02891863 -
Low Energy Therapy to Convert Ventricular Tachycardias
|
Phase 0 | |
Terminated |
NCT01546207 -
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
|
N/A | |
Completed |
NCT01294267 -
Percutaneous Hemodynamic Support With Impella 2.5 During Scar-related Ventricular Tachycardia Ablation
|
N/A | |
Terminated |
NCT00383799 -
Iv Amiodarone Versus Iv Procainamide to Treat Haemodynamically Well Tolerated Ventricular Tachycardia
|
Phase 4 | |
Completed |
NCT04884100 -
enHEART - Exploring Full Content of Optical Signals to Enhance Cardiac Arrhythmia Screening
|
N/A | |
Completed |
NCT04642963 -
Stereotactic Management of Arrhythmia - Radiosurgery in Treatment of Ventricular Tachycardia
|
N/A | |
Recruiting |
NCT05377216 -
Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation
|
Early Phase 1 | |
Not yet recruiting |
NCT04990089 -
VIVO European Observational Registry
|
||
Completed |
NCT04065893 -
Impact of Catheter Ablation of Ventricular Arrhythmias on Suboptimal Biventricular Pacing in Cardiac Resynchronization Therapy
|
||
Recruiting |
NCT03631303 -
Post-Extrasystolic Potentiation as a Predictor of Ventricular Arrhythmias
|
||
Recruiting |
NCT03611465 -
Creation of a Pace-mapping Atlas on Healthy and Pathological Hearts
|
N/A |